Doseology Sciences Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a DOSEF research report →
Price Chart
About the company
Doseology Sciences Inc. , through its subsidiary, Dose Labs Inc. , engages in the research, development, and sale of functional mushroom products with a focus on mental health research in Canada.
- CEO
- Kareem Baalbaki
- IPO
- 2022
- Employees
- 3
- HQ
- Kelowna, BC, CA
Get TickerSpark's AI analysis on DOSEF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $433.36K
- P/E
- -0.40
- PEG
- 0.01
- P/S
- 5.96
- P/B
- 5.20
- EV/EBITDA
- -0.28
- Div Yield
- 0.00%
- Gross Margin
- -628.75%
- Op Margin
- -1498.09%
- Net Margin
- -1618.07%
- ROE
- -164.81%
- ROIC
- -1308.68%
Latest fiscal year · YoY change
- Revenue
- $103.96K+232.6%
- Gross Profit
- $-777,162-4215.2%
- Op Income
- $-1,557,427
- Net Income
- $-1,682,154-411.4%
- EPS
- $-0.21-194.1%
- OCF Growth
- -248.5%
- FCF Growth
- -248.5%
- 52W High
- $1.00
- 52W Low
- $0.01
- 50D MA
- $0.11
- 200D MA
- $0.24
- Beta
- 2.29
- RSI (14)
- 1
- Avg Volume
- 5
No earnings-call transcripts are available for DOSEF yet.
- Free Float
- 43.2%
- Shares Outstanding
- 4.50M
- Float Shares
- 1.94M
Our DOSEF coverage
Recent articles, reports, and earnings notes.
No research on DOSEF yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate DOSEF report →Doseology Announces Results of Its Annual General Meeting
newsfilecorp.com · Nov 18
Doseology Announces Revocation of MCTO and Adoption of Semi-Annual Financial Reporting
newsfilecorp.com · Nov 5
Doseology Announces Management Cease Trade Order for Late Filing of Annual Audited Financial Statements
newsfilecorp.com · Oct 29
Doseology Announces Resignation of Director
newsfilecorp.com · Oct 14
Doseology Announces Director and Officer Changes; Completes Shares-for-Debt Settlement
prnewswire.com · Sep 30
Doseology Announces Proposed Shares-for-Debt Settlement and Resignation of Director
prnewswire.com · Sep 23
Doseology Announces $2M Financing to Accelerate Commercialization of Oral Stimulant Pouch Platform
prnewswire.com · Mar 30
Doseology Uplists to OTCQB as DOSEF, Expanding U.S. Investor Access to the Emerging Oral Stimulant Pouch Category
prnewswire.com · Mar 11
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.